Aspire Biopharma Holdings, Inc. (ASBP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aspire Biopharma Holdings, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -9.67x | -759.42x | 1403.63x | 3324.75x | -321316.99x |
| P/B Ratio | -37.14x | -6181.98x | 320.03x | 38.42x | -17232737.38x |
| P/S Ratio | 38181.40x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | |||||
| Gross Margin | -1.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -312016.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -394725.1% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -312016.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | |||||
| Current Ratio | 0.17x | 0.09x | 0.20x | 3.62x | 1.00x |
| Quick Ratio | 0.14x | 0.09x | 0.20x | 3.62x | 1.00x |
| Leverage | |||||
| Debt/Equity | -0.22x | -0.82x | 0.00x | 0.00x | -502.31x |
YoY = year-over-year change. Source: FMP..